Cargando…
A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
BACKGROUND: Bladder cancer (BLCA) is one of the deadliest diseases, with over 550,000 new cases and 170,000 deaths globally every year. Cuproptosis is a copper-triggered programmed cell death and is associated with the prognosis and immune response of various cancers. Long non-coding RNA (lncRNA) co...
Autores principales: | Bai, Yuchen, Zhang, Qi, Liu, Feng, Quan, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9701814/ https://www.ncbi.nlm.nih.gov/pubmed/36451815 http://dx.doi.org/10.3389/fimmu.2022.1027449 |
Ejemplares similares
-
A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA
por: Yang, Mingyi, et al.
Publicado: (2022) -
A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma
por: Wang, Xinyi, et al.
Publicado: (2023) -
Construction of a cuproptosis‐related lncRNA signature for predicting prognosis and immune landscape in osteosarcoma patients
por: Ni, Shumin, et al.
Publicado: (2022) -
Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma
por: Xu, Yifan, et al.
Publicado: (2022) -
Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme
por: Shi, Dongjie, et al.
Publicado: (2022)